Percutaneous biopsy for prognostic testing of neuroblastoma

Radiology

Volumn 200, Issue 1, 1996, Pages 213-216

  Hoffer, Fredric A ^a   Chung, Taylor ^a   Diller, Lisa ^a,b   Kozakewich, Harry ^a   Fletcher, Jonathan A ^a,b   Shamberger, Robert C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biopsies, technology; Neoplasms, in infants and children; Neuroblastoma

Indexed keywords

ADOLESCENT; ARTICLE; BIOPSY; CHILD; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROBLASTOMA; ONCOGENE C MYB; PERCUTANEOUS BIOPSY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029893355     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.200.1.8657913     Document Type: Article

References (27)

1. McGahey BE, Moriarty AT, Nelson WA, Hull MT. Fine-needle aspiration biopsy of small round blue cell tumors of childhood. Cancer 1992; 69:1067-1073.
2. Hoffer FA, Shamberger RC, Kozakewich H. Percutaneous chest biopsies in children. Cardiovasc Intervent Radiol 1990; 13:32-35.
3. Hoffer FA, Gianturco L, Fletcher J, et al. Percutaneous biopsy of peripheral primitive neuroectodermal tumors and Ewing's sarcomas for cytogenetic analysis. AJR 1994; 162:1141-1142.
4. Hiyama E, Yokayama T, Ichikawa T, et al. N-myc amplification and other prognosis associated factors in neuroblastoma. J Pediatr Surg 1990; 25:1095-1099.
5. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313:1111-1116.
6. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 1991; 9:581-591.
7. Bourhis J, Dominici C, McDowell H, et al. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. J Clin Oncol 1991; 9:1371-1375.
8. Hayashi Y, Inaba T, Hanada R, et al. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastoma in infants. Med Pediatr Oncol 1989; 17:111-115.
9. Kaneko Y, Kanada N, Maseki N, et al. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 1987; 47:311-318.
10. Fong C, White PS, Peterson K, et al. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 1992; 52:1780-1785.
11. Hedborg F, Lindgren PG, Johansson I, et al. N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis. Med Pediatr Oncol 1992; 20:292-300.
12. Brodeur GM, Fong C. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 1989; 41:153-174.
13. Brodeur G, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
14. Shimada H, Chatten J, Newton WA, et al. Histologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73:405-416.
15. Fletcher JA, Kozakewich HP, Hoffer FA, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft tissue tumors. N Engl J Med 1991; 324:436-443.
16. Shapiro, DN, Valentine MB, Rowe ST, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization; diagnostic utility for neuroblastoma. Am J Pathol 1993; 142:1339-1345.
17. Favrot MC, Combaret V, Lasset C. CD44: a new prognostic marker for neuroblastoma. N Engl J Med 1993; 329:1965.
18. Gross N, Beretta C, Peruisseau G, et al. CD44H expression by human neuroblastoma cells: relation to N-myc amplification and lineage differentiation. Cancer Res 1994; 54:4238-4242.
19. Nitschke R, Smith EI, Shochat S, et al. Localized neuroblastoma treated by surgery: a pediatric oncology group study. J Clin Oncol 1988; 6:1271-1279.
20. August CA, Serota FT, Koch PA, et al. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 1984; 2:609-616.
21. Kern JA, Daniel TM, Tribble CC, et al. Thoracoscopic diagnosis and treatment of mediastinal masses. Ann Thorac Surg 1993; 56:92-96.
22. Hasse GM, Wong KY, deLorimier AA, et al. Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 1989; 24:194-200.
23. West DC, Shamberger RC, Macklis RM, et al. Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 1993; 11:84-90.
24. LaQualia MP, Kushner BH, Heller G, et al. Stage 4 neuroblastoma diagnosed at more than one year of age: gross total resection and clinical outcome. J Pediatr Surg 1994; 29:1162-1166.
25. Le Tourneau JN, Bernard JL, Hendren WH, et al. Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 1985; 20:244-249.
26. Shamberger RC, Allarde-Segundo A, Kozakewich HP, Grier HE. Surgical management of stage III and IV neuroblastoma: resection before or after chemotherapy. J Pediatr Surg 1991; 26:1113-1118.
27. Franklin IM, Pritchard J. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies. J Clin Pathol 1983; 36:1215-1218.